Production (Stage)
Elicio Therapeutics, Inc.
ELTX
$8.08
-$0.19-2.30%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 54.82% | 36.64% | 75.30% | -84.20% | 38.28% |
Total Receivables | -- | -- | -98.04% | -84.38% | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 20.06% | -31.99% | 322.50% | -16.82% | -42.91% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 4.14% | 39.04% | -63.65% | -32.95% | -67.62% |
Total Current Assets | 48.16% | 26.58% | 53.76% | -74.49% | 2.26% |
|
|||||
Total Current Assets | 48.16% | 26.58% | 53.76% | -74.49% | 2.26% |
Net Property, Plant & Equipment | -15.42% | -14.99% | -14.47% | -14.38% | -14.83% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -61.38% | -63.16% | -63.23% | -34.09% | -2.61% |
Total Assets | 14.97% | 3.80% | 23.88% | -58.13% | -3.91% |
|
|||||
Total Accounts Payable | 265.34% | -76.24% | -54.97% | -75.26% | -73.64% |
Total Accrued Expenses | 73.59% | 123.98% | 9.87% | 86.65% | 111.32% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 5.11% | -0.99% | -6.50% | -13.30% | 23.13% |
Total Finance Division Other Current Liabilities | 6.08% | 62.59% | -24.28% | 4,134.38% | -48.70% |
Total Other Current Liabilities | 6.08% | 62.59% | -24.28% | 4,134.38% | -48.70% |
Total Current Liabilities | 91.78% | 18.12% | -21.47% | -0.16% | -66.25% |
|
|||||
Total Current Liabilities | 91.78% | 18.12% | -21.47% | -0.16% | -66.25% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -15.99% | -15.02% | -14.11% | -13.30% | -12.29% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -62.35% | 25,609.09% | -- | 9,143.48% | 13,559.72% |
Total Liabilities | -1.89% | 150.36% | 224.13% | 23.75% | -19.27% |
|
|||||
Common Stock & APIC | 34.64% | 18.96% | 10.05% | 9.36% | 2,986.76% |
Retained Earnings | -33.29% | -36.50% | -35.15% | -31.54% | -33.90% |
Treasury Stock & Other | 30.00% | 6.34% | -101.14% | -155.26% | -- |
Total Common Equity | 82.83% | -199.46% | -242.90% | -107.01% | 104.43% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 82.83% | -199.46% | -242.90% | -107.01% | 104.43% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 82.83% | -199.46% | -242.90% | -107.01% | 311.32% |
|